Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio Growth (5y) (2016 - 2023)
Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio Growth (5y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Supernus Pharmaceuticals | 2.57 Bn | 2.19 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -34.12% |
| Mar 31, 2023 | -39.88% |
| Dec 31, 2022 | -2.29% |
| Sep 30, 2022 | -14.87% |
| Jun 30, 2022 | -57.45% |
| Mar 31, 2022 | -64.77% |
| Dec 31, 2021 | 14.89% |
| Sep 30, 2021 | -43.81% |
| Jun 30, 2021 | -36.28% |
| Mar 31, 2021 | -42.98% |
| Dec 31, 2020 | 17.10% |
| Sep 30, 2020 | -11.94% |
| Jun 30, 2020 | -7.57% |
| Mar 31, 2020 | -13.79% |
| Dec 31, 2019 | 4.32% |
| Sep 30, 2019 | 70.22% |
| Jun 30, 2019 | 21.88% |
| Mar 31, 2019 | 19.03% |
| Dec 31, 2018 | 23.30% |
| Sep 30, 2018 | 27.97% |